Does a Nasal Instillation of Vardenafil Normalize the Nasal Potential Difference in Cystic Fibrosis Patients?
Does a Nasal Instillation of Vardenafil Normalize the Nasal Potential Difference in Cystic Fibrosis Patients Homozygous for the F508del Mutation? A Randomized, Double Blind, Placebo-controlled Study.
Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Terminated
not yet started
Other terminated trials from Cliniques universitaires Saint-Luc- Université Catholique de Louvain
- Hypopharynx Squamous Cell Carcinoma · Phase PHASE2 · Mar 2025
- Adipose Tissue · Phase NA · Apr 2024
- Febrile Neutropenia, Drug-Induced · Phase NA · Dec 2022
- Cancer · Phase NA · Apr 2022
- Chronic Obstructive Pulmonary Disease · Phase NA · Dec 2021
See all terminations from Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Other Cystic Fibrosis trials with similar outcome
This PHASE2 trial investigates Cystic Fibrosis and is currently terminated or withdrawn. Cliniques universitaires Saint-Luc- Université Catholique de Louvain leads this study, which shows 6 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE2
-
Mar 2019 — Jan 2021 [monthly]
Terminated PHASE2
Status: Suspended → Terminated
-
Jun 2018 — Mar 2019 [monthly]
Suspended PHASE2
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Suspended PHASE2
First recorded
Oct 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Cliniques universitaires Saint-Luc- Université Catholique de Louvain
For direct contact, visit the study record on ClinicalTrials.gov .